AIM RULE 26

The information below is disclosed in accordance with Rule 26 of the AIM Rules for Companies and was last updated on 1 December 2022.

Business Description

Please click on the link below for a description of the business.
Investor Overview

Board of Directors

Please click here for names and brief biographical details of each of the directors.

Annual and Interim Reports

Please click on this link to access the Company's Annual and Interim Reports

Corporate Governance

The Directors have decided to apply the 2018 Quoted Companies Alliance Corporate Governance Code (“the QCA Code”). Please click here for more detail on how the Company complies with the QCA Code, together with reasons for any departure from it.

Country of Incorporation and Main Country of Operation

The Company is incorporated in England and Wales, with registered number 06227084.

Its main centre of operation is Oxford, UK, and it has overseas operations in the USA, Malaysia and Singapore.

UK Takeover Code

The Company is subject to the UK City Code on Takeovers and Mergers.

Current constitutional documents

Please click on this link for access to our Key Corporate Documents, including the Company's Articles of Association.

Details of any other exchanges or trading platforms

The Company’s shares are not traded on any other stock exchange.

The number of AIM securities in issue

The Company does not hold any Ordinary Shares in treasury and therefore the number of Ordinary Shares with voting rights is 146,712,380.

Number of AIM securities not in public hands

The percentage of AIM securities not in public hands is 37.7%.

Significant shareholders

The identity and percentage holdings of significant shareholders as notified to the Company:

Name of Shareholder Number of Ordinary Shares Percentage of Issued Share Capital
Odey Asset Management LLP 26,945,092 18.37%
Vulpes Life Sciences Fund 16,909,203 11.52%
Vulpes Testudo Fund 2,004,971 1.37%
Unicorn Asset Management 10,000,000 6.82%
Christian Hoyer Millar and Family 9,195,370 6.27%
Investec Wealth & Investment Ltd 7,346,886 5.00%
Alexandre Akoulitchev 6,303,082 4.30%
The Chancellor, Masters and Scholars of the University of Oxford 5,724,476 3.90%
Aroul Ramadass and Family 5,490,468 3.74%
GL Healthcare Investment L.P. 4,688,000 3.20%

Please submit TR1 notifications to investorrelations@oxfordbiodynamics.com

Significant shareholder information last updated on 1 December 2022.

Details of any restrictions on the transfer of AIM securities

There are no restrictions on the transfer of the Company’s Ordinary Shares.

Regulatory notifications

Please click on the link to access notifications made by the Company in the past five years.
Regulatory news

AIM admission document and circulars

Please click on the link below to access the Company's most recent admission document and circulars or similar publications sent to shareholders within the past 12 months, as well as any prospectus issued since 3 January 2018.
Key Corporate Documents

Directors' responsibilities

Please click here for details of the of the responsibilities of the members of the board of directors and the subcommittees of the Board.

Advisors

Please click on the link below for details of the Company's Nominated Adviser and other key advisers.
Investor Contacts